Inhibition of the elevated rate of translation with a small molecule inhibitor is a promising strategy for suppressing MYCN‐dependent tumor growth and is reportedly effective for controlling the high‐risk MYCN‐driven NB [31, 32]. Here, MYCN is linked to neuroblastoma.